Skip to main content
Home

Topics navigation

Animals
Climate Crisis
Conflict Regions
Culture
Democracy
Development & Aid
Economy
Education
Energy
Environment
Exemplary People
Food & Agriculture
Globalization
Health
Human Rights
Men
Military
Nature
News Media
Nuclear Disarmament
Peace
Politics
Religions
Social Justice
Sustainability
Women
Youth
Useful Tools
Real News
Events
  • News
Search
  • de
  • / EN

Main navigation

  • Us
    • About Us
    • Endorsements
    • Privacy Policy
    • FAQ
    • Publisher
    • Disclaimer
    • Press
  • You
    • Get Involved
    • What can I do?
    • Add a Link
    • Share knowledge
    • Donate
    • Contact us
Topics Search
  • News

Social Media Links

Bluesky
X
LinkedIn
Facebook
YouTube
Instagram
Tiktok
Switch to German site (opens in a new window)

share

Other COVID-10 Drugs

  • Home
  • Health
  • Info by Disease
  • Infections
  • Novel Coronavirus Guide
  • COVID-19 DRUGS
  • Other COVID-10 Drugs
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cancel
  • From nasal vaccines to pills: the next defences against Covid - Guardian 15.08.22 300496
  • Paxlovid rebound happens, though why and to whom are still a mystery - Stat News 02.08.22 375902
  • Arthritis drug could help save Covid patients – study - Guardian 03.03.22 277525
  • Doctors have an arsenal of Covid-19 treatments, but setbacks and shortages are undercutting options - StatNews 07.01.22 274864
  • Investigating Antidepressants’ Surprising Effect on COVID Deaths - Scientific American 12.11.21 262669
  • Pfizer pill significantly cuts risk of COVID-19 death, company says - Politico 05.11.21 260911
  • Merck wants Americans to pay $712 for a Covid drug that taxpayers helped develop - Guardian 14.10.21 257883
  • Why Merck’s Covid-19 pill molnupiravir could be so important - VOX 12.10.21 257884
  • How antiviral pill molnupiravir shot ahead in the COVID drug hunt - Nature 08.10.21 257881
  • 'Entirely unsurprising': Merck slammed for 4,000% markup of taxpayer-funded covid drug - CD 06.10.21 257527
  • How Merck's antiviral pill could change the game for COVID-19 - Nat Geo 01.10.21 256793
  • Merck’s COVID pill cuts deaths, hospitalisations by half: Report - Al Jazeera 01.10.21 256525
  • Fraudulent ivermectin studies open up new battleground between science and misinformation - Guardian 24.09.21 257773
  • Desperation, misinformation: how the ivermectin craze spread across the world - Guardian 24.09.21 256001
  • India’s medicine makers in logistical ‘mess’ as coronavirus crisis disrupts pharmaceutical supply chain - SCMP 18.05.21 246079
  • Coronavirus disease 2019 and cardiovascular system: A narrative review - Pub Med 03.06.20 241469
  • Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - Lancet 09.04.21 241475
  • Artificial intelligence can now design new antibiotics in a matter of days - Vox 03.04.21 240790
  • With Great Caution, Scientists Seek Covid Treatments in Old Drugs - UNDARK 30.03.21 240328
  • Arthritis drug that helps Covid ICU patients has wider benefits, trial finds - Guardian 11.02.21 235855
  • Gout drug could reduce Covid hospital stays, new research finds - Guardian 04.02.21 237884
  • Even with vaccines, we still need treatments for Covid. So what works? - Guardian 02.02.21 237263
  • Relationship between antidepressants and severity of SARS-CoV-2 Omicron infection: a retrospective cohort study using real-world data - Lancet 27.02.23 238136
  • SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - NCBI 04.03.20 201934
  • How COVID-19 is demanding a new look at Indigenous healing in the Amazon - The Humanitarian 26.08.20 215335
  • Coronavirus: Madagascar pursues clinical trials of injectable remedy - The Africa Report 12.06.20 212218
  • The Efficacy of Ivermectin Against COVID‑19 - Covid19criticalcare 238890
Bluesky
X
LinkedIn
Facebook
YouTube
Instagram
Tiktok
to top
  • About Us
    • FAQ
    • Endorsements
    • Privacy Policy
    • Disclaimer
    • Publisher
    • Press
  • Get Involved
    • What can I do?
    • Add a Link
    • Share knowledge
    • Donate
    • Contact Us
Privacy
Details
Imprint | Privacy
Your selection from
The controller (Dr. Norbert Stute, Austria) would like to use the following services in order to process your personal data. Technologies such as cookies, localStorage, etc. can be used for personalization. This is not necessary for the use of the website, but allows us to interact with you more closely. If you wish, you can adjust or revoke your consent at any time via our privacy policy.
Switch to accept or reject the service